Researchers have also identified variations in the microbiota across breast cancer types (e.g., Human Epidermal Receptor Growth Factor 2-positive, triple-negative, and endocrine-receptor positive breast cancers), and these variations extend beyond the bacterial composition of breast tissue to other resident microbes, such as viruses and fungi (9). This evidence concerns the gene ERBB2 and breast cancer.